Immediate Impact
60 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Metabolic reprogramming of macrophages by a nano-sized opsonization strategy to restore M1/M2 balance for osteoarthritis therapy
2025 Standout
Works of Fengkai Xu being referenced
Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma
2020
B cells expressing CD11b effectively inhibit CD4+ T‐cell responses and ameliorate experimental autoimmune hepatitis in mice
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Fengkai Xu | 622 | 186 | 230 | 310 | 34 | 938 | |
| Zhennan Yuan | 444 | 148 | 245 | 307 | 30 | 917 | |
| Weihua Liang | 582 | 160 | 224 | 314 | 54 | 873 | |
| Rifat Hasina | 604 | 212 | 324 | 269 | 38 | 1.1k | |
| Jiong Li | 779 | 114 | 300 | 240 | 32 | 1.1k | |
| Saket Jain | 441 | 101 | 242 | 264 | 29 | 869 | |
| Maria Christina Tsourlakis | 748 | 394 | 191 | 317 | 38 | 1.0k | |
| Renaud Grépin | 588 | 151 | 269 | 272 | 26 | 892 | |
| Qianshan Ding | 517 | 123 | 191 | 251 | 42 | 842 | |
| Guangzhi Wang | 484 | 101 | 159 | 313 | 48 | 887 | |
| Xiaoxiang Rong | 463 | 160 | 278 | 405 | 26 | 830 |
All Works
Loading papers...